Heat Biologics Inc.

AMEX: HTBX · Real-Time Price · USD
2.38
0.01 (0.42%)
At close: May 03, 2022, 6:00 AM

Heat Biologics Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
825.52K 1.15M 2.1M 2.45M 2.58M
Cost of Revenue
n/a n/a n/a n/a n/a
Gross Profit
825.52K 1.15M 2.1M 2.45M 2.58M
Operating Income
-35.78M -35.42M -28.95M -30.51M -28.64M
Interest Income
740.85K 815.32K 884.62K 829.89K 709.17K
Pretax Income
-36.11M -35.55M -28.35M -29.71M -27.63M
Net Income
-35.9M -35.12M -27.96M -29.38M -27.29M
Selling & General & Admin
15.84M 16.83M 14.29M 17.48M 16.43M
Research & Development
19.35M 18.82M 16.2M 14.99M 13.56M
Other Expenses
1.88M 1.88M n/a n/a n/a
Operating Expenses
37.07M 37.53M 30.49M 32.47M 29.99M
Interest Expense
661.73K 541.03K n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a
Cost & Expenses
37.07M 37.53M 30.49M 32.47M 29.99M
Income Tax Expense
86.06K -16.53K 601.48K 799.33K 1.01M
Shares Outstanding (Basic)
25.59M 25.14M 25.14M 25.14M 24.2M
Shares Outstanding (Diluted)
25.59M 25.14M 25.14M 25.14M 24.2M
EPS (Basic)
-1.42 -1.41 -1.14 -1.27 -1.36
EPS (Diluted)
-1.42 -1.41 -1.14 -1.27 -1.36
EBITDA
-35.49M -35.13M -27.45M -28.96M -26.92M
EBIT
-21.28M -13.21M n/a n/a n/a
Depreciation & Amortization
-20.45K -125.76K 505.8K 416.32K 367.36K